Short answer
agilon health, inc. (AGL) filed an 8-K current report with the SEC on April 27, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Tim O’Rourke becomes CEO, President, and Class III director on May 7, 2026, bringing extensive healthcare-sector leadership experience.
agilon health, inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Tim O’Rourke becomes CEO, President, and Class III director on May 7, 2026, bringing extensive healthcare-sector leadership experience
- Base salary $850,000 with 100% target annual bonus opportunity
- $500,000 signing bonus, repayable for qualifying departure before the first anniversary
- Equity package includes 120,000 three-year RSUs and 200,000 PSUs tied to stock-price targets of $50, $100, and $150
- Termination protection includes 18 months’ salary, target bonus, medical coverage, and limited equity acceleration without cause or for good reason
Item 7.01 · Regulation FD Disclosure
- CEO and President appointment: Mr. O’Rourke named to both roles
- Board appointment: Mr. O’Rourke added as a director
- Leadership transition disclosed April 27, 2026; Exhibit 99.1 contains appointment details
Item EX-99.1 · Exhibit EX-99.1
- Tim O’Rourke appointed CEO and board member effective May 7, succeeding Ronald Williams
- Williams remains Chairman, preserving leadership continuity after the operational and financial transformation
- O’Rourke brings more than 25 years across Medicare Advantage, payor operations, provider care delivery, and value-based care
- Leadership focus shifts toward scaling physician partnerships, disciplined contracting, cost management, and value-based growth
- Platform spans approximately 2,300 PCPs across approximately 30 communities
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other agilon health, inc. 8-K filings
Get the next AGL 8-K as it lands
Follow AGL for push alerts, or ask the research agent what this filing means.